Chemical activators of Olr257 can achieve their effects through several pathways that converge on the common mechanism of protein kinase A (PKA) activation due to increased levels of cyclic adenosine monophosphate (cAMP). Forskolin, a direct stimulator of adenylyl cyclase, can rapidly elevate cAMP concentrations, which in turn activates PKA. This activated PKA can phosphorylate Olr257, thereby leading to its functional activation. Similarly, Isoproterenol, a synthetic analog of epinephrine, binds to beta-adrenergic receptors and enhances cAMP production. The elevated cAMP acts as a second messenger to activate PKA, which then targets Olr257 for activation through phosphorylation.
Adenylyl cyclase can also be modulated by a variety of other compounds that either stimulate the enzyme directly or prevent the degradation of cAMP. IBMX acts as a non-selective inhibitor of phosphodiesterases, preventing the breakdown of cAMP and resulting in sustained PKA activation, which can activate Olr257. Epinephrine, like isoproterenol, operates through adrenergic receptors to increase cAMP and activate Olr257 via PKA. Histamine, acting through its receptors, and dopamine, through D1-like receptors, both increase cAMP production, engaging PKA in the activation process of Olr257. Prostaglandin E2, binding to its EP receptors, and adenosine, acting through its own receptors, both serve to elevate cAMP levels with the subsequent activation of Olr257 by PKA. Vardenafil, by selectively inhibiting phosphodiesterase-5, leads to an increase in cAMP and activates PKA, which phosphorylates and activates Olr257. Glucagon, by activating its receptor, fosters increased cAMP production, with downstream PKA activation and subsequent action on Olr257. PACAP, through PAC1 receptors, also raises cAMP levels and activates PKA, culminating in Olr257 activation. Cholera toxin, through modification of the Gs alpha subunit, causes a prolonged activation of adenylyl cyclase, leading to sustained cAMP and PKA activation, which in turn facilitates the phosphorylation and activation of Olr257. Each of these chemical activators can initiate a cascade that ultimately results in the functional activation of Olr257, demonstrating the diverse but interconnected pathways that regulate this protein's activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Activates beta-adrenergic receptors increasing cAMP levels, thereby activating PKA which then can phosphorylate and activate Olr257. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-selective inhibitor of phosphodiesterases, increasing cAMP levels and thus activating PKA, which in turn can phosphorylate and activate Olr257. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Interacts with adrenergic receptors increasing cAMP production, which leads to PKA activation, and subsequent phosphorylation and activation of Olr257. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Through its G protein-coupled receptors can increase cAMP levels, leading to the activation of PKA and subsequent phosphorylation and activation of Olr257. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Through D1-like receptors, increases cAMP levels and activates PKA, which can then phosphorylate and activate Olr257. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Binds to EP receptors which increases cAMP levels and activates PKA, leading to phosphorylation and activation of Olr257. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Inhibits phosphodiesterase-5, thus increasing cAMP levels and activating PKA, which in turn can phosphorylate and activate Olr257. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Activates adenosine receptors, which increases cAMP levels and activates PKA, subsequently phosphorylating and activating Olr257. | ||||||
PACAP(6-38) | 137061-48-4 | sc-391136 sc-391136A | 500 µg 1 mg | $540.00 $932.00 | ||
Through PAC1 receptors, increases cAMP levels, leading to PKA activation and the phosphorylation and activation of Olr257. | ||||||